2m 2m 2m 2m 2m 2m 2m
ARVINAS (ARVN)
NASDAQ
$6.78-$0.14 (-2.10%)
Price as of Nov 11, 2026 7:30 PM EST- $453.2MMarket Cap
- -38.27%1-Year Change
- BiotechnologyIndustry
ARVINAS (ARVN)
$6.78-$0.14 (-2.10%)
ARVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.92 | ||
Change | +$0.16 (+2.37%) | ||
Open | $6.57 | ||
High | $6.93 | ||
Low | $6.49 | ||
Previous Close | $6.76 | ||
Volume | 702,748 | ||
30-Day Average Volume | 893,896 | ||
1-Week Change | -2.40% | ||
1-Month Change | -9.42% | ||
1-Year Change | -38.27% | ||
3-Year Change | -53.84% | ||
5-Year Change | -92.04% | ||
Fundamentals | |||
Shares Outstanding | 65.5M | ||
Total Assets | $607.5M | ||
Market Cap | $453.2M | ||
Enterprise Value | $365.6M | ||
Period: QTR TTM FY | |||
Revenue | $500,000.00 | ||
Net Income | -$53.9M | ||
Free Cash Flow | -$10.2M | ||
EBIT | -$53.7M | ||
EBITDA | -$53.1M | ||
Net Working Capital | $517.6M | ||
EPS | -$0.82 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 731 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -44 | ||
Price/Operating Cash Flow | -44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue